Change of Registered Office and IR Appointment

By

Regulatory News | 31 Aug, 2021

Updated : 12:00

RNS Number : 2316K
SigmaRoc PLC
31 August 2021
 

 

31 August 2021

(EPIC: SRC / Market: AIM / Sector: Construction Materials)

 

SIGMAROC PLC

 ('SigmaRoc' or the 'Company')

 

Change of Registered Office and Investor Relations Appointment

 

SigmaRoc, the AIM quoted buy-and-build construction materials group, is pleased to announce that it has changed its registered office to Suite 1, 15 Ingestre Place, London, W1F 0DU with immediate effect. 

 

As previously notified, Dean Masefield has stepped down from the board of directors and resumed the role that he previously held, Deputy Chief Financial Officer for the PPG, Channel Islands, South Wales and Benelux platforms. In addition, Dean has assumed the role of Head of Investor Relations.

 

 

For further information, please contact:

 

SigmaRoc plc

Max Vermorken

 

Tel: +44 (0) 207 002 1080

Strand Hanson Limited (Nominated and Financial Adviser)

James Spinney / James Dance / Rob Patrick

 

Tel: +44(0) 207 409 3494

Liberum Capital (Co-Broker)

Neil Patel / Jamie Richards / William Hall

 

Tel: +44 (0) 203 100 2000

 

 

Peel Hunt (Co-Broker)

Mike Bell / Ed Allsopp

 

Tel: +44 (0) 20 7418 8900

Investor Relations

Dean Masefield / Florian Werner

Tel: +44 (0) 207 002 1080

ir@sigmaroc.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CROWPUAWRUPGGUG

Last news